Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Natco Pharma CEO discusses impact of U.S. tariffs on Indian pharma industry and strategies for diversification and growth.

Nivin Pauly is set to venture into the digital space with 'Pharma,' a multilingual web series directed by PR Arun, premiering ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

Directed by PR Arun, the series explores the ethical complexities of India's pharmaceutical industry through the journey of a ...

To navigate the post-LDC era successfully, Bangladesh must transition from a volume-driven, generics-dominated model to one ...

Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.

India seeks to significantly boost its medicine exports to Mexico, a market currently valued at over $20 billion and expected ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.

Hikal Ltd. VP discusses India's rise in pharmaceutical contract manufacturing, projecting significant growth in global market ...